Invention Grant
US08476271B2 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators
有权
取代的喹喔啉型桥接哌啶化合物作为ORL-1调节剂
- Patent Title: Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators
- Patent Title (中): 取代的喹喔啉型桥接哌啶化合物作为ORL-1调节剂
-
Application No.: US13010632Application Date: 2011-01-20
-
Publication No.: US08476271B2Publication Date: 2013-07-02
- Inventor: Naoki Tsuno , Jiangchao Yao
- Applicant: Naoki Tsuno , Jiangchao Yao
- Applicant Address: US CT Stamford JP
- Assignee: Purdue Pharma, L.P.,Shionogi & Co., Ltd.
- Current Assignee: Purdue Pharma, L.P.,Shionogi & Co., Ltd.
- Current Assignee Address: US CT Stamford JP
- Agency: Dechert LLP
- Main IPC: A61K31/495
- IPC: A61K31/495

Abstract:
Compounds of Formula (I): where R1, R2, R5, a, and b are disclosed herein, and pharmaceutically acceptable derivatives thereof (a “Substituted-Quinoxaline-Type Bridged-Piperidine Compound”), compositions comprising an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound.
Public/Granted literature
- US20110178090A1 SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUNDS AND THE USES THEREOF Public/Granted day:2011-07-21
Information query